Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe new screenshot shows only minor UI updates and no changes to core study content like eligibility criteria, primary outcomes, enrollment, or locations; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check37 days agoChange Detected- Added a government funding notice and operating status guidance, plus a v3.2.0 revision tag. - Removed the term 'Ovarian cancer' and an older v3.0.2 revision tag. If ovarian cancer was part of the core content, its removal could affect topic scope, but overall the page now emphasizes current status and updated version.SummaryDifference2%

- Check38 days agoChange DetectedUpdated page to v3.1.0; removed the term 'Ovarian cancer' and the older version reference v3.0.2.SummaryDifference0.1%

- Check53 days agoChange DetectedUpgrade: The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link was removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe webpage has updated its version from v3.0.0 to v3.0.1 and has changed the last update date to September 5, 2025, while removing previous update dates from May and June 2025.SummaryDifference0.5%

- Check67 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional resources related to various cancers, while removing outdated information and certain genetic resources.SummaryDifference21%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.